Skip to main content
Rapport Therapeutics, Inc. logo

Rapport Therapeutics, Inc. — Investor Relations & Filings

Ticker · RAPP ISIN · US75383L1026 US Manufacturing
Filings indexed 168 across all filing types
Latest filing 2026-05-07 Interim / Quarterly Rep…
Country US United States of America
Listing US RAPP

About Rapport Therapeutics, Inc.

https://www.rapportrx.com/

Rapport Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering and developing transformational small molecule medicines for patients with central nervous system (CNS) disorders. The company employs a precision medicine approach, focusing on neuroanatomically precise targeting to create therapies with the potential for powerful efficacy and fewer side effects. Its pipeline is centered on advancing new medications for a range of neurological conditions.

Recent filings

Filing Released Lang Actions
10-Q - Rapport Therapeutics, Inc. (0002012593) (Filer)
Interim / Quarterly Report
2026-05-07 English
8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)
Regulatory Filings
2026-05-07 English
ARS - Rapport Therapeutics, Inc. (0002012593) (Filer)
Annual Report
2026-04-23 English
DEF 14A - Rapport Therapeutics, Inc. (0002012593) (Filer)
Proxy Solicitation & Information Statement
2026-04-23 English
8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)
Regulatory Filings
2026-04-21 English
144 - Rapport Therapeutics, Inc. (0002012593) (Subject)
Regulatory Filings
2026-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.